Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02471287 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genetics of Inherited Eye Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 84 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Re-verified, no change to tracked fields
  3. Minor Re-verified, no change to tracked fields
  4. Minor Secondary endpoints: details revised at 1 of 4 entries
  5. Minor 11 versions Re-verified since Aug 13, 2025, no change to tracked fieldsv70-v80
Show 35 earlier versionsHide 35 earlier versions
  1. Notable Primary and study completion dates: Sep 1, 2025 to Sep 1, 2030v69
  2. Minor 3 versions Re-verified since Apr 4, 2025, no change to tracked fieldsv66-v68
  3. Minor Study Status, Study Descriptionv65
  4. Minor 4 versions Re-verified since Mar 18, 2025, no change to tracked fieldsv61-v64
  5. Minor Enrollment target: 1250 to 1500v60
  6. Minor 2 versions Re-verified since Oct 12, 2024, no change to tracked fieldsv58-v59
  7. Notable Primary and study completion dates: Sep 1, 2024 to Sep 1, 2025v57
  8. Minor 11 versions Re-verified since Nov 23, 2022, no change to tracked fieldsv46-v56
  9. Notable Primary and study completion dates: Sep 1, 2023 to Sep 1, 2024v45
  10. Minor Re-verified, no change to tracked fieldsv44
  11. Minor Site contact updatedv43
  12. Minor Study Status, Contacts/Locationsv42
  13. Minor 3 versions Re-verified since Mar 15, 2022, no change to tracked fieldsv39-v41
  14. Notable Primary and study completion dates: Sep 1, 2022 to Sep 1, 2023v38
  15. Minor 3 versions Re-verified since Dec 11, 2020, no change to tracked fieldsv35-v37
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Research has identified some of the genes involved in inherited eye diseases. But for many of these diseases, the genes are not yet known. Researchers want to try to find these genes. They also hope to learn more about how symptoms differ in people with similar gene changes. Objective: To learn more about genes involved in eye diseases. Eligibility: People who have a known or suspected inherited eye disease, and their relatives. Design: * All participants will have a medical history, physical exam, and eye exam. They will have blood taken. * Participants with an eye disease may have eye cell samples taken using a swab or biopsy procedure. * Participants may have a skin biopsy. A 3mm piece of skin will be removed. * Participants may provide samples of tears, urine, saliva, stool, hair, or inner cheek cells. * Participants may have a retina test. They may also have a test that uses light to measure retina thickness. * Participants may have an eye movement test. Electrodes will be placed on the skin next to both eyes. * Participants may have a fluorescein angiography. A dye will be given through an intravenous line in the arm. A camera will take pictures of the dye as it flows through the eyes blood vessels. * Participants may have microperimetry. They will sit at a computer screen and press a button when they see a light. * Participants may have an eye movement test. They will wear contact lenses or goggles and watch a series of spots on a computer screen. * Participants may complete a color vision test. * Participants will provide a specimen for genetic testing. * Participants may have a MRI. * Participants may complete questionnaires.
Trial Details
NCT Number NCT02471287
Lead Sponsor National Eye Institute (NEI)
Conditions
(from sponsor)
Genetic Eye Disease
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov